港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

610.821

0.000

漲家數：14

跌家數：1

平家數：19

市盈率：- -

高：610.821

開：610.821

低：610.821

收：610.821

成交量：- -

成交額：- -

市值：3,893.54億

流通市值：3,472.70億

資料載入中...

總覽新聞資訊

上市後首份年報出爐，英硅智能如何以BD走穩商業化？

21世纪经济报道

醫保監管新規細化違法行為認定，重點打擊倒賣迴流藥、誘導住院

東曜藥業－Ｂ(01875)股價下跌8.127%，現價港幣$5.2

阿斯达克财经

港股微創心通-B午後一度跌近17%

每日经济新闻

創新藥概念午後再度活躍海創藥業升逾11%

每日经济新闻

2026年一季度創新藥BD交易突破600億美元！恒生創新藥ETF華泰柏瑞（520500）成交額顯著放量

加科思－Ｂ(01167)股價下跌5.125%，現價港幣$6.85

阿斯达克财经

德琪醫藥－Ｂ(06996)股價下跌5.112%，現價港幣$4.64

阿斯达克财经

貝康醫療2025業績亮點：從IVD到IVF全場景AI平台，成為中國輔助生殖領域行業龍頭

盈利33倍，和鉑醫藥憑什麼成為「確定性資產」？

榮昌生物(09995)出現大手賣出5.35萬股，成交價$95.0，涉資508.25萬

阿斯达克财经

港股異動 | 醫藥外包概念走強，昭衍新藥績後升逾13%，凱萊英升逾11%

老虎资讯综合

A股開盤速遞 | 三大指數升跌不一白酒板塊快速拉升創新藥概念反覆活躍

智通财经网

貝康醫療-B(02170)發布年度業績，收入2.33億元核心產品註冊、國產化推進及平台型業務佈局方面取得多項重要進展

微創心通-B(02160)發布年度業績股東應占虧損1881.9萬元按年擴大170.85%

華昊中天醫藥-B(02563)股份全流通獲聯交所授出上市批准

《業績》開拓藥業(09939.HK)全年虧損擴至2億人民幣

阿斯达克财经

康希諾生物(06185)公布2025年業績實現收入約10.59億元按年增長28.43%

和鉑醫藥-B(02142)公布2025年業績税後溢利9222.1萬美元按年增長約32.63倍

億騰嘉和(06998)3月30日斥資65.88萬港元回購25.45萬股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":610.8213,"timestamp":1775006922636,"preClose":610.8213,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"開市前","change":0,"latestTime":"04-01 09:28:42","open":610.8213,"high":610.8213,"low":610.8213,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1775007000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1775007000000,1775016000000],[1775019600000,1775030400000]],"pbRate":4.826672,"peRate":-78.974737,"turnoverRate":0.004135,"increases":0,"decrements":0,"flats":33,"marketCap":389354234080,"floatMarketCap":347269640640},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":610.8213,"amplitude":0,"preClose":610.8213,"low":610.8213,"pbRate":"4.826672","latestPrice":610.8213,"volume":0,"delay":0,"open":610.8213,"prevYearClose":556.26263,"prevWeekClose":606.745,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":577.933,"twentyDayClose":497.711,"sixtyDayClose":557.843,"secType":"PLATE","market":"HK","turnoverRate":0.004135,"peRate":-78.974737,"marketCap":389354234080,"floatMarketCap":347269640640,"timestamp":1775006922636,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":14,"down":1,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623930549","title":"上市後首份年報出爐，英硅智能如何以BD走穩商業化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623930549","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623930549?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:49","pubTimestamp":1774939740,"startTime":"0","endTime":"0","summary":"3月29日，英硅智能公布了港股上市后的首份年报。紧随其后，英硅智能宣布与礼来达成27.5亿美元合作。根据协议，礼来将获得一项全球独家许可，用于开发、生产和商业化针对特定适应症、目前处于临床前开发阶段的、具有潜在“同类最佳”水平的新型口服治疗药物。此外，英硅智能与礼来还将围绕礼来选定的靶点开展多项研发项目合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690313762.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690313762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK4543","BK4588","AGIX","BK4585","BK4551","BK4023","CHAT","BK1191","AIPO","BK4135","AIYY","CNS","BK4587","AI","BK4528","01477","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623930562","title":"醫保監管新規細化違法行為認定，重點打擊倒賣迴流藥、誘導住院","url":"https://stock-news.laohu8.com/highlight/detail?id=2623930562","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623930562?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:45","pubTimestamp":1774939500,"startTime":"0","endTime":"0","summary":"中国医保基金监管工作将迎来操作性更强的法律制度依据。　　4月1日起，《医疗保障基金使用监督管理条例实施细则》将正式施行。作为2021年发布的《医疗保障基金使用监督管理条例》的一部配套规章，《实施细则》对基金使用、监督检查、违法认定、法律责任等内容进行了系统细化。　　“比如违法行为的认定，仍需要进一步细化。”","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/insurance/bxyy/2026-03-31/doc-inhswicu3316117.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/bxyy/2026-03-31/doc-inhswicu3316117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1574","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623305914","title":"東曜藥業－Ｂ(01875)股價下跌8.127%，現價港幣$5.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2623305914","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623305914?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:35","pubTimestamp":1774938900,"startTime":"0","endTime":"0","summary":"[下跌股]东曜药业－Ｂ(01875) 股价在下午02:35比前收市价下跌8.127%，现股价为港币$5.2。至目前为止，今日最高价为$5.7，而最低价为$5.2。总成交量为280.28万股，总成交金额为港币$1.519千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312621/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312621/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","01875"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623038483","title":"港股微創心通-B午後一度跌近17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623038483","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623038483?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:11","pubTimestamp":1774937489,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月31日，微创心通-B(02160.HK)午后一度跌近17%，截至发稿跌14.38%，报2.62港元，成交额1386.11万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690267428.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690267428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","BK4588","BK1583","BK4585","02160","BK1574","02918","BK1225","BK1239","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623308309","title":"創新藥概念午後再度活躍 海創藥業升逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623308309","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623308309?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 13:50","pubTimestamp":1774936200,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月31日，创新药概念午后再度活跃，海创药业涨超11%，此前津药药业、凯莱英涨停，双鹭药业、首药控股、亚太药业、威尔药业、万邦德、诚达药业跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690242481.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690242481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","159992","BK1574","06978","688302","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623701133","title":"2026年一季度創新藥BD交易突破600億美元！恒生創新藥ETF華泰柏瑞（520500）成交額顯著放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2623701133","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623701133?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 13:36","pubTimestamp":1774935360,"startTime":"0","endTime":"0","summary":"今日早盘，创新药板块延续回暖态势，相关ETF交投火热。　　Wind数据显示，当前全市场仅有的跟踪恒生创新药指数的ETF产品——恒生创新药ETF华泰柏瑞成交额近期显著放量。2026年3月28日，据国家药监局发布信息显示，2026年一季度我国创新药BD交易总额已突破600亿美元，接近2025年全年总额的一半；交易数量达53件，首付款超33亿美元，规模与增速均创历史同期新高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-03-31/doc-inhswawe2210437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520500","BK1574","06978","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370988","title":"加科思－Ｂ(01167)股價下跌5.125%，現價港幣$6.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370988","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370988?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 13:15","pubTimestamp":1774934100,"startTime":"0","endTime":"0","summary":"[下跌股]加科思－Ｂ(01167) 股价在下午01:15比前收市价下跌5.125%，现股价为港币$6.85。至目前为止，今日最高价为$7.34，而最低价为$6.85。总成交量为127.23万股，总成交金额为港币$909.862万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312197/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312197/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370985","title":"德琪醫藥－Ｂ(06996)股價下跌5.112%，現價港幣$4.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370985","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370985?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 13:15","pubTimestamp":1774934100,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药－Ｂ(06996) 股价在下午01:15比前收市价下跌5.112%，现股价为港币$4.64。至目前为止，今日最高价为$4.92，而最低价为$4.64。总成交量为164.95万股，总成交金额为港币$788.222万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312199/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312199/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","06996","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623377568","title":"貝康醫療2025業績亮點：從IVD到IVF全場景AI平台，成為中國輔助生殖領域行業龍頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2623377568","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623377568?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 12:49","pubTimestamp":1774932592,"startTime":"0","endTime":"0","summary":"伴随国产智造与人工智能的双重浪潮，贝康医疗正以确定的盈利预期和坚实的竞争壁垒，叩响辅助生殖赛道价值重估的大门。","market":"sh","thumbnail":"https://img2.gelonghui.com/b17e2-5257232d-3843-4fee-aee1-cf4340bf53a5.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-5257232d-3843-4fee-aee1-cf4340bf53a5.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4247094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1222","AIPO","02170","BK4082","BK1574","IVF","AGIX","BK1597","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623723953","title":"盈利33倍，和鉑醫藥憑什麼成為「確定性資產」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623723953","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623723953?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 12:09","pubTimestamp":1774930173,"startTime":"0","endTime":"0","summary":"和铂医药不再是一家赌临床数据的传统Biotech，而是一个掌握全球稀缺底层技术、具备常态化造血能力、与MNC深度绑定的“技术基建商”。","market":"sh","thumbnail":"https://img2.gelonghui.com/b17e2-c747d72b-9b53-4b59-8164-252fd1f5ff31.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-c747d72b-9b53-4b59-8164-252fd1f5ff31.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4246709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1583","02142","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623372639","title":"榮昌生物(09995)出現大手賣出5.35萬股，成交價$95.0，涉資508.25萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2623372639","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623372639?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 11:53","pubTimestamp":1774929180,"startTime":"0","endTime":"0","summary":"[大手成交]荣昌生物(09995)在上午11:53出现大手卖出，成交量为5.35万，成交价为港币$95.0，涉资508.25万。至目前为止，股价跌3.844%，今日最高价为$101.4，而最低价为$95.0，总成交量为265.4万股，总成交金额港币$2.569亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603314836/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603314836/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","09995","BK0239","LU2488822045.USD","688331","LU1064130708.USD","LU1969619763.USD","BK1574","BK1583","LU2148510915.USD","LU2328871848.SGD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109731579","title":"港股異動 | 醫藥外包概念走強，昭衍新藥績後升逾13%，凱萊英升逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109731579","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109731579?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 09:51","pubTimestamp":1774921897,"startTime":"0","endTime":"0","summary":"3月31日，医药外包概念走强，$昭衍新药(06127)$涨超13%，$凯莱英(06821)$涨超11%，$康龙化成(03759)$涨超6%，$药明生物(02269)$、$泰格医药(03347)$涨超5%","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821","LU1328615791.USD","BK1161","06127","BK4588","BK1191","09939","BK0239","BK1574","BK0216","BK1515","BK4585","BK1141","BK1576","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623376462","title":"A股開盤速遞 | 三大指數升跌不一 白酒板塊快速拉升 創新藥概念反覆活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2623376462","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623376462?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 09:51","pubTimestamp":1774921872,"startTime":"0","endTime":"0","summary":"3月31日，A股沪指高开0.02%，深成指低开0.31%，创业板指低开0.80%。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260331/20260331095128_13566.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260331/20260331095128_13566.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159982","159992","06978","BK1161","BK1574","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623328501","title":"貝康醫療-B(02170)發布年度業績，收入2.33億元 核心產品註冊、國產化推進及平台型業務佈局方面取得多項重要進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2623328501","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623328501?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 01:24","pubTimestamp":1774891440,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布截至2025年12月31日止年度业绩，该集团取得收入2.33亿元，同比减少22.01%;公司权益股东应占亏损2.23亿元，同比减少5.7%;每股亏损0.8元。2025年，对本集团而言，是由“研发及注册驱动”逐步迈向“商业化落地及经营优化驱动”的关键一年。报告期内，本集团在核心产品注册、国产化推进及平台型业务布局方面取得多项重要进展。于男科领域，家用精子检测设备获批上市，进一步完善本集团在辅助生殖前端检测场景的产品布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"贝康医疗-B(02170)发布年度业绩，收入2.33亿元 核心产品注册、国产化推进及平台型业务布局方面取得多项重要进展","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02170","BK1597","BK1574","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623340317","title":"微創心通-B(02160)發布年度業績 股東應占虧損1881.9萬元 按年擴大170.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623340317","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623340317?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 00:48","pubTimestamp":1774889327,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创心通-B(02160)发布截至2025年12月31日止年度业绩，收入5704.4万美元，同比增加12.28%;股东应占亏损1881.9万元，同比扩大170.85%;每股基本亏损0.04美元。公告称，收入增长主要是由于集团自2025年12月19日起合并微创®心律管理后自CRM业务录得收入;及随着VitaFlow Liberty®自由•维心流TM及Alwide® Plus敖广®Plus全球商业化持续推进，结构性心脏病业务海外收入较截至2024年12月31日止年度快速增长 255.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"微创心通-B(02160)发布年度业绩 股东应占亏损1881.9万元 同比扩大170.85%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02160","BK1225","BK1583","BK1100","02918","BK1239","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623347972","title":"華昊中天醫藥-B(02563)股份全流通獲聯交所授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2623347972","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623347972?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 00:26","pubTimestamp":1774888017,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B(02563)发布公告，公司已向联交所上市委员会申请批准将由1.48亿股非上市股份转换所得的1.48亿股H股上市及准许买卖。董事会欣然宣布，联交所已于2026年3月20日授出上市批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09939","BK1515","02563","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623134760","title":"《業績》開拓藥業(09939.HK)全年虧損擴至2億人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2623134760","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623134760?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 00:17","pubTimestamp":1774887420,"startTime":"0","endTime":"0","summary":"开拓药业－Ｂ(09939.HK) 公布2025年度业绩，收入录得3,262万人民币(下同)，按年增加553.6%。亏损由上年度1.55亿元，扩至2亿元，每股亏损44分。不派末期息。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2025/08/28中期业绩无派息2025/03/26末期业绩无派息2024/08/26中期业绩无派息2024/03/28末期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200511160928560_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200511160928560_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1514353/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1514353/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["CYB","MCNHmain","09939","BK1574","UCmain","BK1515","MUCmain","CNHmain","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623478333","title":"康希諾生物(06185)公布2025年業績 實現收入約10.59億元 按年增長28.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623478333","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623478333?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 00:07","pubTimestamp":1774886865,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺生物 公布2025年业绩，收入约10.59亿元，同比增长28.43%;年内利润2787.3万元，同比扭亏为盈;每股盈利0.11元。自2022年推出四价流脑结合疫苗曼海欣和二价流脑结合疫苗美奈喜以来，两款疫苗为预防婴幼儿流脑疾病提供了更为高效、优质的疫苗选择。2025年，随着流脑疫苗产品的推广和市场导入，两款流脑结合疫苗实现销售收入约9.677亿元，同比增长21.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物(06185)公布2025年业绩 实现收入约10.59亿元 同比增长28.43%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06185","BK1515","BK1191","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623434187","title":"和鉑醫藥-B(02142)公布2025年業績 税後溢利9222.1萬美元 按年增長約32.63倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2623434187","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623434187?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 22:49","pubTimestamp":1774882160,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)公布2025年业绩，收入约1.58亿美元，同比增长314.63%;年内溢利9222.1万美元，同比增长约32.63倍;基本每股盈利0.12美元。于2025年，公司全面迈入3.0战略阶段，由三大增长引擎协同驱动：将诺纳生物打造为AI驱动的全球抗体药物发现“新基建”;与跨国制药公司建立长期、平台化的战略合作伙伴关系，以加速全球扩张;通过Harbour Therapeutics实现在自免、肿瘤等领域的中后期资产全球价值的最大化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"和铂医药-B(02142)公布2025年业绩 税后溢利9222.1万美元 同比增长约32.63倍","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623834675","title":"億騰嘉和(06998)3月30日斥資65.88萬港元回購25.45萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623834675","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623834675?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 22:16","pubTimestamp":1774880212,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿腾嘉和(06998)发布公告，于2026年3月30日斥资65.88万港元回购25.45万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422192.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06998","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":2,"totalSize":336,"code":"91000000","status":"200"}]}}